These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 2610083)

  • 21. Hydroxyproline analogs of bradykinin.
    Stewart JM; Ryan JW; Brady AH
    J Med Chem; 1974 May; 17(5):537-9. PubMed ID: 4830258
    [No Abstract]   [Full Text] [Related]  

  • 22. Chemical structure and biological activity relationship in bradykinin analogues containing proline-like unusual amino acids.
    Baláspiri L; Tóth MV; Lonovics J; Kovács K
    Acta Biochim Biophys Hung; 1986; 21(4):363-7. PubMed ID: 3109180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. DesArg10[Hoe 140] is a potent B1 bradykinin antagonist.
    Wirth KJ; Wiemer G; Schölkens BA
    Agents Actions Suppl; 1992; 38 ( Pt 2)():406-13. PubMed ID: 1334341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Highly selective bradykinin agonists and antagonists with replacement of proline residues by N-methyl-D- and L-phenylalanine.
    Reissmann S; Schwuchow C; Seyfarth L; Pineda De Castro LF; Liebmann C; Paegelow I; Werner H; Stewart JM
    J Med Chem; 1996 Feb; 39(4):929-36. PubMed ID: 8632416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclic analogue of bradykinin possessing selective and prolonged biological activity.
    Chipens GI; Mutulis FK; Katayev BS; Klusha VE; Misina IP; Myshlyiakova NV
    Int J Pept Protein Res; 1981 Sep; 18(3):302-11. PubMed ID: 7341523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cardiovascular and gastrointestinal effects of bradykinin and its potentiation by thiols in rats.
    Sherman WT; Gautieri RF
    J Pharm Sci; 1969 Aug; 58(8):971-5. PubMed ID: 5344532
    [No Abstract]   [Full Text] [Related]  

  • 27. Differentiation of bradykinin receptors and of kininases with conformational analogues of bradykinin.
    LeDuc LE; Marshall GR; Needleman P
    Mol Pharmacol; 1978 May; 14(3):413-21. PubMed ID: 207969
    [No Abstract]   [Full Text] [Related]  

  • 28. Structure-activity relationships of bradykinin potentiating peptides.
    Ufkes JG; Visser BJ; Heuver G; Van der Meer C
    Eur J Pharmacol; 1978 Jul; 50(2):119-22. PubMed ID: 679977
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A new class of bradykinin antagonists containing indanylglycine.
    Gera L; Stewart JM
    Immunopharmacology; 1996 Jun; 33(1-3):174-7. PubMed ID: 8856143
    [No Abstract]   [Full Text] [Related]  

  • 30. Bradykinin antagonists do not require a D-aromatic amino acid residue at position 7.
    Vavrek RJ; Gera L; Stewart JM
    Agents Actions Suppl; 1992; 38 ( Pt 1)():572-81. PubMed ID: 1466298
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The studies on the active peptide on smooth muscle in the skin of Rana rugosa, Thr6-Bradykinin and its analogous peptide, ranakinin-R.
    Yasuhara T; Ishikawa O; Nakajima T; Araki K; Tachibana S
    Chem Pharm Bull (Tokyo); 1979 Feb; 27(2):486-91. PubMed ID: 445684
    [No Abstract]   [Full Text] [Related]  

  • 32. Discrimination between putative bradykinin B2 receptor subtypes in guinea pig ileum smooth muscle membranes with a selective, iodinatable, bradykinin analogue.
    Liebmann C; Bossé R; Escher E
    Mol Pharmacol; 1994 Nov; 46(5):949-56. PubMed ID: 7969085
    [TBL] [Abstract][Full Text] [Related]  

  • 33. L-3,4-dehydroproline analogs of bradykinin. Synthesis, biological activity, and solution conformation.
    Fisher GH; Marlborough DI; Ryan JW; Felix AM
    Arch Biochem Biophys; 1978 Jul; 189(1):81-5. PubMed ID: 708052
    [No Abstract]   [Full Text] [Related]  

  • 34. A novel bradykinin antagonist with improved properties.
    Lammek B; Wang YX; Gavras I; Gavras H
    J Pharm Pharmacol; 1991 Dec; 43(12):887-8. PubMed ID: 1687595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The competitive antagonistic effect of compounds from Mandevilla velutina on kinin-induced contractions of rat uterus and guinea-pig ileum in vitro.
    Calixto JB; Pizzolatti MG; Yunes RA
    Br J Pharmacol; 1988 Aug; 94(4):1133-42. PubMed ID: 3207977
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bradykinin chemistry: agonists and antagonists.
    Stewart JM; Vavrek RJ
    Adv Exp Med Biol; 1983; 156():585-9. PubMed ID: 6134438
    [No Abstract]   [Full Text] [Related]  

  • 37. New and highly potent bradykinin antagonists.
    Knolle J; Breipohl G; Henke S; Wirth K; Schölkens B
    Agents Actions Suppl; 1992; 38 ( Pt 1)():559-64. PubMed ID: 1334632
    [No Abstract]   [Full Text] [Related]  

  • 38. Bradykinin B1 receptors in the rabbit urinary bladder: induction of responses, smooth muscle contraction, and phosphatidylinositol hydrolysis.
    Butt SK; Dawson LG; Hall JM
    Br J Pharmacol; 1995 Feb; 114(3):612-7. PubMed ID: 7735687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. D-Arg[Hyp3-Thi5-D-Tic7-Tic8]-bradykinin, a potent antagonist of smooth muscle BK2 receptors and BK3 receptors.
    Farmer SG; Burch RM; Kyle DJ; Martin JA; Meeker SN; Togo J
    Br J Pharmacol; 1991 Apr; 102(4):785-7. PubMed ID: 1649657
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of drug receptor theories to the analysis of the myotropic effects of bradykinin.
    Barabe J; Park WK; Regoli D
    Can J Physiol Pharmacol; 1975 Jun; 53(3):345-53. PubMed ID: 238724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.